INSTATRADER'S LONG TERM OTC WINNERS!!!!

[Jimmy Quick]

$RXMD Making Investing Easy so you can Sleep Easy
REAL COMPANY - OTCQB – Penny Stock Exempt, 2 YEARS AUDITED FINANCIALS soon to be 3, Over 20 MILLION NET ANNUAL REVS and soon to be over 40 MILLION NET REVENUES – HUGE LONGTERM INVESTMENT POTENTIAL

What's happening for RXMD?

11 things specifically come to mind, and they keep generating more "Game Changers" by the week. WOW!!

1. December 2018 revenues were reported. Done – Press Release January 15th

Progressive Care Inc. Announces Best December in Company History

MIAMI, FL -- January 15, 2019 -- InvestorsHub NewsWire -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of prescriptions filled for December 2018.

In December, the company reported a total of $1.7 million in net revenue, a 6% increase from the same month last year, and a 45% increase in prescriptions filled during the same month last year, totaling nearly 28,332 prescriptions filled. This marks the strongest finish to the year in Company history.

"December was another big month for us. Progressive Care exceeded December 2017 prescription fillings and is moving forward on major initiatives," said S. Parikh Mars, CEO of Progressive Care. "In December, we finalized the closing of our first property and are eagerly pushing forward on an agenda that will capitalize on our many achievements in 2018. We are confident that 2019 will lead to continued growth, more record-breaking months, and even bigger milestones while we continue our high standards for patient service and value-added healthcare management offerings."

REVENUES ACHIEVED YTD


2. $18 Million Annual Revenue Purchase of Florida Base Pharmacy, as pretty much confirmed by the new Funding Facility Agreement - Terms were Great by the Way – Kudos Benchmark on the Assistance.


$18 Million Annual Revenue Purchase of Florida Base Pharmacy (SEE PRESS RELEASE dated 11/27/18 BELOW), as pretty much confirmed by the new Funding Facility Agreement - Terms were Great by the Way – Kudos Benchmark on the Assistance.

Acquisition update issued January 16, 2019. “We believe that acquisition will be conducted in stages similar to that of PharmCo 1002, starting in a few weeks and completing in the second quarter of 2019.”

This means Entry into Material Definitive Agreement should be in a few weeks that would consummate the deal and turn management duties over to Progressive Care. Then starting 2nd quarter we would be able to start recognizing the revenues once government pharmacy provider changes are complete.

Another Update January 28, 2019
Conversation with Armen

They need to sign many agreements with the seller, he mentioned three or four, like “Seller’s Agreement, Employment Agreement”, etc. They have been working very actively on these with the seller and their attorney. The current versions of all these agreements are in the hands of the seller’s attorney. Progressive Care is just waiting for their replies. Armen said because this is such a huge acquisition, both parties are taking their time to review the documents. Armen said as soon as everything falls into place, they will update shareholders in PR.

Progressive Care Signs Letter of Intent to Purchase Florida Based Pharmacy with $18 million in Annual Revenue

MIAMI, FL -- November 28, 2018 -- InvestorsHub NewsWire -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has entered into a letter of intent to purchase a Florida based pharmacy with 2 operating locations.

On November 27, 2018, Progressive Care executed a letter of intent to purchase a Florida based pharmacy with locations in Davie and Orlando, Florida. The target pharmacy had just under $16 million in revenue in 2017 and is projected to have approximately $18 million for 2018. The agreement calls for a stratified payment structure for the total purchase price of $3,000,000. $2.3 million in cash spread over 2 years and $700,000 in stock valued at market price at closing or $0.07 whichever is lower. The signing is expected to take place no later than January 15, 2019 after the completion of a 45-day due diligence period.

"We have devoted our efforts to grow the company and expand its geographical coverage," said S. Parikh Mars, Chief Executive Officer of Progressive Care Inc. "This LOI is a significant step towards our development and presence in the industry. We are excited to add another pharmacy with its exceptional team to our family and platform."

3. Annual Shareholder Letter for 2019 Forecast and Goals – Done: Press Release 1/17/2019
Ms. Shital Mars, CEO will share the outlook for 2019 and highlights from 2018.

Progressive Care OUTLOOK
The following are our strategic goals for 2019:
• Achieve 40,000 prescriptions filled in a single month
• Increase annual same store sales to $24 million
• Close on second acquisition leading to consolidated revenue of over $35 million
• Secure additional 340B contracts and long-term care facility relationships
• Achieve accreditation for non-sterile compounding
• Achieve full enterprise profitability and earnings growth
• Install Tele-PharmCo enabled kiosks and equipment in senior living communities and large-scale clinics
• Develop exclusive line of CBD products
• Conduct PharmCo evidence-based case studies
• Release PharmCo's first televised advertisement
• Become SEC registered and fully reporting

4. 3rd Year of Audited Financial Statements and Conference Call to Discuss Results.


5. CBD Manufacturer Partnership Agreement

Putting all the below together and you get….

Armen said they are currently working on the final agreements and some other related work. He is positive this project is moving forward as planned.

Update January 28, 2019
Ms. Mars is flying out to San Diego today. Part of her missions is to meet some CBD organizations for partnership! Armen said he wished the federal government could be more liberal on cannabis products, but no matter what, Progressive Care will be getting the best out of it. He is very much looking forward to this huge opportunity for the company’s growth. As to the potential Curaleaf partnership, he only said they are referring their customers to Curaleaf products as an agreement with Curaleaf. He wants to see where this relationship will lead them to.

Night of January 28, 2019
ProgressiveCare Tweet: Hello San Diego. From CEO MS. SHITAL MARShttps://t.co/5QBgs9yJAL

So we're going to put our name behind these products, which is a big deal. Again not all CBD is made alike. This is going to be our reputation on the line with the CBD brand and we have two manufacturers that we're working on NDA's with to explore those partnerships. So very exciting times. Look out for more updates in January after the Farm bill but we're not waiting for January. We're trying to get things in place so that once the Farmville passes, we can start moving forward on production.

6. PharmcoRx Commerical

PharmCoRx Commercial in English and many other languages

https://youtu.be/z642uN9Ppho

7. CBS Miami Interview on “Opioid Weening” going Nationwide

Interviewing CEO Shital Mars, and compounding pharmacist Momina and PharmCo’s patient.



8. Announcement of SEC Registration Completion

Progressive Care will audit the new Orlando pharmacy’s financials once the acquisition is completed. They will file SEC together. He’s still expecting sometime late March, early April.

9. Tele-Pharmacy Licensing Deals

We're are going to be a technology company too. If you look five years from now, CVS, Walgreens, Walmart will be using the solutions we developed and we pioneered and they're going to have to look at us for what we just like the Xerox years ago, had developed all of this tech that were then used by other people.

I don't want to be the Xerox, we're going to own that tech. We're going to be the one you have to come to if you want to advance in the technology sphere of patient management, of healthcare management, of telemedicine, of tele-pharmacy, of whatever. If you're helping a patient and healthcare happens at home, somewhere PharmCo and Progressive Care is going to be involved. So that's the future. That's what we're working toward and that's what all of our shareholders have to look forward to.

10. January 2019 revenues will be reported this WEEK.


11. ProgressiveCare CEO, Shital Park Mars will be speaking at the 17th Cold Chain Global Forum Canada as one of the keynote speakers on February 26, 2019.


ALL OF THIS COULD LEAD TO A SIMILAR SITUATION AS BELOW IN THE FUTURE IN TERMS OF VALUATION – AGAIN HUGE LONGTERM INVESTEMENT POTENTIAL

LOOK AT AMAZONS BUY OF PILLPACK for around $1 Billion, and PillPack revenues were $100 million. RXMD has a ton of revenues. Over $20 million net revenues for FY 2018 and has acquired 2nd location.